The Midwest – with life science strongholds such as Minneapolis-St. Paul, Chicago and Cleveland – has made its mark as an active and thriving region for the development of life science and healthcare technologies.
Recognizing the increasing role of the Midwest in bringing the latest technology and emerging innovations to the investment community, MedCityNews.com has partnered with MidAmerica Healthcare Venture Forum, the showcase that offers the “Best of the Midwest.” This event, held in association with Mid-America Healthcare Investors Network (MHIN), will take place April 22-23, 2014 in Chicago.
MidAmerica Healthcare Venture Forum will unite active investors and corporate business development executives to facilitate investment opportunities with more than 30 of the most promising Midwest-based healthcare start-ups.
Behavioral Health, Interoperability and eConsent: Meeting the Demands of CMS Final Rule Compliance
In a webinar on April 16 at 1pm ET, Aneesh Chopra will moderate a discussion with executives from DocuSign, Velatura, and behavioral health providers on eConsent, health information exchange and compliance with the CMS Final Rule on interoperability.
This important event showcases deal-flow originating in the Midwest and creates an opportunity for companies, university researchers, venture capitalists, economic development professionals and others interested in growing the life science industry in the Midwest to come together.
You will have the chance to hear from and interact with leading healthcare experts and start-up companies spanning the medical device, biopharmaceuticals, regenerative medicine, agri-health, diagnostics, health IT and industrial biotech sectors.
MidAmerica Healthcare Venture Forum is the best place to learn about opportunities to invest in the thriving technology and innovation community that characterizes the Midwest region. Join the best of the Midwest’s healthcare venture capital and start-up communities at the destination healthcare investing conference in the Midwest.
Who attends MidAmerica Healthcare Venture Forum?
A Deep-dive Into Specialty Pharma
A specialty drug is a class of prescription medications used to treat complex, chronic or rare medical conditions. Although this classification was originally intended to define the treatment of rare, also termed “orphan” diseases, affecting fewer than 200,000 people in the US, more recently, specialty drugs have emerged as the cornerstone of treatment for chronic and complex diseases such as cancer, autoimmune conditions, diabetes, hepatitis C, and HIV/AIDS.
° C-level executives from healthcare start-ups
° Venture capitalists, angel investors and investment bankers
° Corporate business development executives and R&D officers
° Tech transfer officers, incubators and healthcare consultants
This conference is a national event for anyone interested in knowing the trends and up-and-coming start-ups in the life sciences and healthcare.
Register today to get the very best rate.
